Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
The use of anti-human signal molecules monoclonal antibod-ies (mAbs) for malignant tumors therapy has achieved consid-erable success in recent years. Antibody drug conjugates are powerful new clinical treatment options for lymphomas and solid tumors, and immunomodulatory antibodies...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
Elmer Press, Inc.
2020
|
| Online Access: | https://hdl.handle.net/1721.1/124938 |